MEDITECH(SH:603990)2026-01-29 10:05Financial Performance Forecast - The company expects a net profit attributable to shareholders of 39 million to 44 million yuan for 2025, a significant turnaround from a net loss of 279.47 million yuan in 2024[5] - The projected net profit after deducting non-recurring gains and losses for 2025 is estimated to be between 10 million and 15 million yuan[5] - The company reported a total profit of -253.73 million yuan and a net profit attributable to shareholders of -279.47 million yuan for 2024[6] - The performance forecast is based on preliminary calculations and has not been audited, with final figures to be disclosed in the official 2025 annual report[9] - The performance forecast period is from January 1, 2025, to December 31, 2025[5] Strategic Initiatives - The main reason for the turnaround is the completion of a major asset sale and the divestment of the photovoltaic business, allowing the company to focus on its core medical business[7] - The company aims to enhance its operational efficiency and cost control through refined management practices, which is expected to improve profitability[7] - The company is focusing on three strategic initiatives: concentrating on the medical core business, enhancing asset-light attributes, and building a platform ecosystem[7] Caution for Investors - The company emphasizes that there are no significant uncertainties that could affect the accuracy of this performance forecast[8] - Investors are advised to be cautious as the forecast data is preliminary and subject to change[9]